Call for innovations: Identifying solutions for cardiometabolic disease management or prevention in humanitarian settings in Sub-Saharan Africa

In unstable humanitarian contexts, care for cardiometabolic diseases, such as diabetes, cardiovascular disease or hypertension, is often severely disrupted. While innovative solutions exist, many remain undocumented and under-recognised.

Funded by the Novo Nordisk Foundation, our collaborative project with the African Population and Health Research Center (APHRC) aims to identify, document, and share community, primary, secondary care-level, or policy innovations that support CMD care across Sub-Saharan Africa.

This project will address critical evidence gaps for CMD management and prevention across Sub-Saharan Africa. By building a stronger evidence base, we can support better decision-making among health actors, inform global practice, and drive commitments from funders and implementers to scale up what works.

Share your innovations with us

We’re looking to connect with those developing or delivering innovative approaches to cardiometabolic disease (CMD) management or prevention in unstable humanitarian settings in Sub-Saharan Africa.

We want to hear from organisations, health actors, researchers, policymakers, communities, and other individuals working with innovations addressing CMDs – including diabetes, gestational diabetes, cardiovascular disease, hypertension and related emergency complications. By sharing your experiences, you will contribute to shaping more effective responses to CMDs in humanitarian settings and ensuring that successful innovations reach the communities that need them most.  

What are we looking for?  

We are interested in any kind of adaptive response that helps with the management or prevention of CMDs in any unstable crisis-affected contexts in Sub-Saharan Africa.  Whilst we will be conducting in-depth contextual reviews in Ethiopia (Somali/Tigray regions) and Northern Uganda, we are interested in reviewing innovations across the region.  
‍
Innovations could include adaptive responses such as:

• Products or tools (eg, claypot insulin storage systems, diabetes survival kits, adaptive food kits).  
• Social or community-led practices (eg, peer support groups to locate insulin, or educational programmes).
• New service delivery models such as adapted, repurposed or integrated programmes (eg, task-shifting models of care, integration of CMD care into sexual and reproductive health programmes).
• Digital solutions (eg, apps used by community health workers).
• Policy or coordination approaches (eg, novel referral mechanisms to secondary care, novel training and educational initiatives).

The innovation should:

• Take place in a crisis-affected setting in Sub-Saharan Africa which results in frequent health care disruption (conflict, displacement, floods, outbreaks, etc.)
• Focus on CMD care such as diabetes, cardiovascular disease, emergency complications of diabetes and cardiovascular diseases, gestational hypertension or diabetes.
• Be either community-led local initiatives, primary or secondary care initiatives led by global or regional institutions, or policy-level responses.
• Show some positive impact, or high potential for impact (formal eg, impact evaluation, or informal eg, discussion with community members).
• Be at any stage – ongoing, piloted or discontinued.
• Have occurred roughly in the last six years.  

How to share your innovation

You can reach out via our online Google form, which takes approximately 5-7 minutes to complete. You can provide a short description to start with, then we can follow up with you to learn more. We will be collecting innovations through this route until the 3 October 2025.  

Please reach out to Dr. Shivani Patel at [email protected] if you have any queries or can facilitate connection to additional networks or relevant literature sources. Alternatively, if you have a repository of multiple innovations in alternative formats (eg, spreadsheets or reports), please also get in touch via email. 

‍